iSTAR Medical presents positive three-year results for MINIject® from STAR-GLOBAL trial For immediate release iSTAR Medical presents positive three-year results for MINIject® from STAR-GLOBAL trial Interim three-year follow-up data further demonstrate consistent safety and efficacy of...

iSTAR Medical initiates international STAR-VI trial for the use of MINIject in conjunction with cataract surgery MINIject® is the only commercially available MIGS implant targeting the supraciliary space Clinical data show positive, consistent results up to two-year follow-up in patients across Europe, Asia, and...